Jack Wenik, Member of the Firm, co-presents an update to the "State of Dietary Supplement Regulations and Litigation" at SupplySide West 2022.
2022 has been a stimulating time for U.S. supplement regulations and legal affairs. The market has seen a bill introduced in Congress that would require manufacturers list their dietary supplement product labels and other information with FDA, a new FDA guidance document related to enforcement discretion on a staple supplement ingredient, class action lawsuits on how products are labeled, a first-time FTC ban of former supplement industry advertisers and more.
Jack and others cover the latest regulatory, legal and legislative developments affecting U.S. manufacturers and marketers of dietary supplements.
Topics include:
- Mandatory product listing and broader reform of the Dietary Supplement Health and Education Act of 1994 (DSHEA)
- NAC, CBD, and other ingredients affected by the “drug exclusion clause”
- Trends in class action litigation
- Update on FTC enforcement
For more information adn to register, please visit west.supplysideshow.com.
